AtriCure has patented a method using high-voltage pulses for tissue ablation, minimizing heating compared to traditional methods. The method involves placing electrodes on the skin, applying specific voltage pulses, and creating lesions in target tissue. This innovative approach offers precise and effective treatment options. GlobalData’s report on AtriCure gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights AtriCure Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on AtriCure, Surgical robots was a key innovation area identified from patents. AtriCure's grant share as of February 2024 was 71%. Grant share is based on the ratio of number of grants to total number of patents.

High-voltage pulses ablation system for tissue lesion creation

Source: United States Patent and Trademark Office (USPTO). Credit: AtriCure Inc

A recently granted patent (Publication Number: US11918271B2) outlines a method for administering an ablation treatment to a patient's skin. The method involves placing a return pad on the patient's skin and positioning an ablation assembly with first and second electrode mechanisms at a target tissue. The assembly delivers high voltage pulses between the electrodes, creating a lesion within the tissue. The pulses have specific parameters, including voltage range, duration, frequency, and number of pulses discharged over a set time interval.

Furthermore, the patent claims specify that the ablation treatment is designed to target myocardial cells, with the goal of either killing a portion of the cells within a certain range of the electrodes or irreversibly damaging the cells. The method also ensures that the application of the high voltage pulse regimen results in minimal cellular damage to the patient's skin near the return pad, with a specified voltage gradient. Overall, the patented method aims to create lesions within the patient target tissue while minimizing damage to surrounding areas, showcasing advancements in the field of skin ablation treatments.

To know more about GlobalData’s detailed insights on AtriCure, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.